Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

More On TLT.V



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Theralase Technologies Inc. (TLT.V)

0.32 Up 0.03(10.34%) Apr 15
Get the big picture on all your investments.
ProfileGet Profile for:
Theralase Technologies Inc.
1945 Queen Street East
Toronto, ON M4L 1H7
Canada - Map
Phone: 416-699-5273

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:N/A

Business Summary 

Theralase Technologies Inc. designs, develops, manufactures, and markets laser technology used in biostimulative and biodestructive clinical applications. The company engages in the production, marketing, and distribution of TLC-1000 and TLC-2000 laser technology for the treatment of chronic pain, neural muscular-skeletal conditions, and wound healing. It is also involved in the commercialization of the patented TLC-3000 photo dynamic compound technology through pre-clinical research, clinical trials, and new technology development in the treatment of cancers for oncological applications and in the destruction of bacteria, viruses, and microbial pathogens; and research and development activities. The company sells its products in Canada, the United States, and internationally. Theralase Technologies Inc. is headquartered in Toronto, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Theralase Technologies Inc.

Key Executives 
Mr. Roger J. Dumoulin-White P.Eng. (Electrical),
Chief Exec. Officer, Pres and Director
Ms. Kristina Hachey ,
Chief Financial Officer
Dr. Arkady Mandel M.D., Ph.D., DSc.,
Chief Scientific Officer
Mr. Greg Bewsh ,
Director of Investor Relations
Mr. Mark Lemieux ,
Corp. Bus. Devel. Officer
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.